✦ LIBER ✦

Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment

✍ Scribed by Kjersem, J.B.; Ikdahl, T.; Lingjaerde, O.C.; Guren, T.; Tveit, K.M.; Kure, E.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetic prediction of clinical o

✍ Paré, L; Marcuello, E; Altés, A; Río, E del; Sedano, L; Salazar, J; Cortés, A; B 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Pharmacogenetic prediction of clinical o

✍ Paré, L; Marcuello, E; Altés, A; del Río, E; Sedano, L; Salazar, J; Cortés, A; B 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

The predictive value of microRNA-126 in

✍ Torben Frøstrup Hansen; Flemming Brandt Sørensen; Jan Lindebjerg; Anders Jakobse 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 467 KB

Biweekly XELOX (capecitabine and oxalipl

✍ Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Vill 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

FCGR2AandFCGR3Apolymorphisms and clinica

✍ Kjersem, Janne B; Skovlund, Eva; Ikdahl, Tone; Guren, Tormod; Kersten, Christian 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 384 KB

High expression of microRNA-625-3p is as

✍ Rasmussen, Mads H.; Jensen, Niels F.; Tarpgaard, Line S.; Qvortrup, Camilla; Røm 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 804 KB